Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: The European group experience

Leukemia

Volumn 19, Issue 2, 2005, Pages 230-233

  Ades, L ^a   Chevret, S ^a   De Botton, S ^a   Thomas, X ^a   Dombret, H ^a   Beve, B ^a   Sanz, M ^a   Guerci, A ^a   Miguel, J S ^a   dela Serna, J ^a   Garo, C ^a   Stoppa, A M ^a   Reman, O ^a   Stamatoulas, A ^a   Fey, M ^a   Cahn, J Y ^a   Sotto, J J ^a   Bourhis, J H ^a   Parry, A ^a   Chomienne, C ^a   Degos, L ^a   Fenaux, Pierre ^a   more..

^a AVICENNE HOSPITAL   (France)

Author keywords

Acute promyelocytic leukemia; ATRA; Elderly

Indexed keywords

ANTHRACYCLINE; ARSENIC DERIVATIVE; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; RETINOIC ACID;

ADULT; AGED; AGING; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG DOSE REGIMEN; DRUG SENSITIVITY; EUROPE; FEMALE; HEART FAILURE; HUMAN; INCIDENCE; KIDNEY FAILURE; LOW DRUG DOSE; LOW ENERGY RADIATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 13544263566     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403597     Document Type: Article

References (16)

1. Fenaux P, Chomienne C, Degos L. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol 2001; 38: 13-25.
2. Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 1999; 94: 1192-1200.
3. Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T et al. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group. Blood 1995; 85: 1202-1206.
4. Sanz MA, Martin G, Gonzalez M, Leon A, Rayon C, Rivas C et al. Programa de Estudio y Traitmiento de las Hemopatias Malignas. Risk-adapted treatment of acute promyelocytic leukemia with all-transretinoic acid and anthracycline monochemotherapy: a multicenter study the PETHEMA group. Blood 2004; 103: 1237-1243.
5. Sanz M, Vellenga E, Rayon C, Diaz-Mediavilla J, Rivas C, Amutio E et al. All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia. Blood 2004, August 3 [E-pub ahead of print].
6. Warrell Jr RP, Maslak P, Eardley A, Heller G, Miller Jr WH, Frankel SR. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Leukemia 1994; 8: 929-933.
7. de Botton S, Coiteux V, Chevret S, Rayon C, Vilmer E, Sanz M et al. Outcome of childhood acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy. J Clin Oncol 2004; 22 1404-1412.
8. Mandelli F, Latagliata R, Avvisati G, Fazi P, Rodeghiero F, Leoni F et al. Treatment of elderly patients (>or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA w
9. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451-458.
10. Fenaux P, Pollet JP, Vandenbossche-Simon JL. Treatment of acute promyelocytic leukemia. A report on 70 cases. Leukemia Lymphoma 1991; 4: 239-246.
11. Cunningham I, Gee TS, Reich LM, Kempin SJ, Naval AN, Clarkson BD. Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood 1989; 73: 1116-1122.
12. Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial. Blood 1999; 93: 4131-4143.
13. Hiddemann W, Kern W, Schoch C, Fonatsch C, Heinecke A, Wormann B et al. Management of acute myeloid leukemia in elderly patients. J Clin Oncol 1999; 17: 3569-3576.
14. Estey E, Thall PF, Pierce S, Kantarjian H, Keating M. Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine. J Clin Oncol 1997; 15: 483-490.
15. Niu C, Yan H, Yu T, Sun HP, Liu JX, Li XS et al. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood 1999; 94: 3315-3324.
16. Lu DP, Qiu JY, Jiang B, Wang Q, Liu KY, Liu YR et al. Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. Blood 2002; 99: 3136-3143.